Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease

Circulation

Volumn 106, Issue 22, 2002, Pages 2800-2805

  Minuz, Pietro ^a,e   Patrignani, Paola ^b   Gaino, Stefania ^a   Degan, Maurizio ^a   Menapace, Laura ^a   Tommasoli, Rosamaria ^a   Seta, Francesca ^b   Capone, Marta L ^b   Tacconelli, Stefania ^b   Palatresi, Simone ^c   Bencini, Chiara ^c   Del Vecchio, Cecilia ^c   Mansueto, Giancarlo ^a   Arosio, Enrico ^a   Santonastaso, Clara Lechi ^a   Lechi, Alessandro ^a   Morganti, Alberto ^c   Patrono, Carlo ^b,d  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e Medicina Interna C   (Italy)

Author keywords

Angiotensin; Hypertension; Renin; Stenosis; Thromboxane

Indexed keywords

11 OXOTHROMBOXANE B2; 8 ISOPROSTAGLANDIN F2 ALPHA; ALPHA TOCOPHEROL; ANGIOTENSIN; ANTIOXIDANT; ASCORBIC ACID; CHOLESTEROL; CREATININE; GLUCOSE; HOMOCYSTEINE; ISOPROSTANE DERIVATIVE; RETINOL; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOPLASTY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; KIDNEY VEIN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PERIPHERAL VEIN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR DISEASE; THROMBOCYTE ACTIVATION; URINARY EXCRETION;

ADOLESCENT; ADULT; AGED; ANGIOPLASTY; ANGIOTENSIN II; ANTIOXIDANTS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DINOPROST; F2-ISOPROSTANES; FEMALE; HOMOCYSTEINE; HUMANS; HYPERTENSION; HYPERTENSION, RENOVASCULAR; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; PLATELET ACTIVATION; REFERENCE VALUES; RENAL ARTERY OBSTRUCTION; RENIN; RENIN-ANGIOTENSIN SYSTEM; THROMBOXANE B2; TRIGLYCERIDES; VITAMINS;

EID: 0037180471     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000039528.49161.E9     Document Type: Article

References (31)

1. Textor SC, Wilcox CS. Renal artery stenosis: A common, treatable cause of renal failure? Annu Rev Med. 2001;52:421-442.
2. Johansson M, Herlitz H, Jensen G, et al. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis: Relation to sympathetic activation, renal function and treatment regimens. J Hypertens. 1999;17:1743-1750.
3. Fatica RA, Port FK, Young EW. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis. 2001;37:1184-1190.
4. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin-II-mediated cardiovascular and renal diseases. Pharmacol Rev. 2000;52:11-34.
5. Laursen JB, Rajagopalan S, Galis Z, et al. Role of superoxide in angiotensin-II-induced but not catecholamine-induced hypertension. Circulation. 1997;95:588-593.
6. Lerman LO, Nath KA, Rodriguez-Porcel M, et al. Increased oxidative stress in experimental renovascular hypertension. Hypertension. 2001;37:541-546.
7. Caps MT, Perissinotto C, Zierler RE, et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation. 1998;98:2866-2872.
8. Patrono C, FitzGerald GA. Isoprostanes: Potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol. 1997;17:2309-2315.
9. 2-isoprostanes) in smokers: Smoking as a cause of oxidative damage. N Engl J Med. 1995;332:1198-1203.
10. 2α is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1997;17:3230-3235.
11. 2α and platelet activation in diabetes mellitus: Effects of improved metabolic control and vitamin E supplementation. Circulation. 1999;99:224-229.
12. 2 receptors. J Clin Invest. 1992;90:136-141.
13. 2α increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO. Arterioscler Thromb Vasc Biol. 1998;18:1248-1256.
14. 2 receptor in vivo. Circulation. 2000;101:2833-2840.
15. Morganti A, Marana I, Airoldi F, et al. Renovascular hypertension: Clinical and diagnostic clues. Ann Urol. 1999;33:137-143.
16. Krijnen P, van Jaarsveld BC, Steyerberg EW, et al. A clinical prediction rule for renal artery stenosis. Ann Intern Med. 1998;129:705-711.
17. Pickering TG. Diagnosis and evaluation of renovascular hypertension: Indications for therapy. Circulation. 1991;83:I-147-I-154.
18. Morganti A, Grassi G, Giannattasio C, et al. Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension. J Hypertens. 1989;7:825-835.
19. Ciabattoni G, Davi G, Collura M, et al. In vivo lipid peroxidation and platelet activation in cystic fibrosis. Am J Respir Crit Care Med. 2000;162:1195-1201.
20. Cipollone F, Ciabattoni G, Patrignani P, et al. Oxidant stress and aspirininsensitive thromboxane biosynthesis in severe unstable angina. Circulation. 2000;102:1007-1013.
21. Davi G, Di Minno G, Coppola A, et al. Oxidative stress and platelet activation in homozygous homocystinuria. Circulation. 2001;104:1124-1128.
22. Voutilainen S, Morrow JD, Roberts LJ, 2nd, et al. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol. 1999;19:1263-1266.
23. Pickering TG, Sos TA, Vaughan ED, Jr, et al. Predictive value and changes of renin secretion in hypertensive patients with unilateral renovascular disease undergoing successful renal angioplasty. Am J Med. 1984;76:398-404.
24. Airoldi F, Palatresi S, Marana I, et al. Angioplasty of atherosclerotic and fibromuscular renal artery stenosis: Time course and predicting factors of the effects on renal function. Am J Hypertens. 2000;13:1210-1217.
25. Griendling KK, Minieri CA, Ollerenshaw JD, et al. Angiotensin-II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
26. Jaimes EA, Galceran JM, Raij L, Angiotensin-II induces superoxide anion production by mesangial cells. Kidney Int. 1998;54:775-784.
27. Rajagopalan S, Kurz S, Munzel T, et al. Angiotensin-II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: Contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916-1923.
28. Haas JA, Krier JD, Bolterman RJ, et al. Low-dose angiotensin-II increases free isoprostane levels in plasma. Hypertension. 1999;34:983-986.
29. 2-isoprostanes in rats. Hypertension. 2000;35:476-479.
30. Ortiz MC, Sanabria E, Manriquez MC, et al. Role of endothelin and isoprostanes in slow pressor responses to angiotensin-II. Hypertension. 2001;37:505-510.
31. 2 receptors maintain hypertension throughout 2K,1C Goldblatt hypertension in the rat. Am J Physiol. 1996;271:R891-R896.